A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering. . . . → Read More: Multi-Drug Resistance Antibiotic Developer to Issue IPO
|
|||||
       |
 Comments are closed  Finance  biomedical, biotechnology, clinical trials, entrepreneurs, equity, investment, IPO, life sciences, pharmaceuticals An analysis of health care costs shows increasing the use of substitute biologic treatments known as biosimilars could save the United States some $54 billion over 10 years. . . . → Read More: Biosimilars Seen Saving U.S. $54 Billion One comment - (Comments are closed) Regulations biomedical, biotechnology, economics, FDA, life sciences, pharmaceuticals, statistics Two companies in Northern Ireland, U.K. are creating a technology platform applying big data analytics to a collection of brainwaves generated by mobile games for measuring cognitive health. . . . → Read More: Big Data Analysis Platform for Brainwaves in Development Comments are closed Joint ventures/collaborations biomedical, clinical trials, engineering, entrepreneurs, Europe, life sciences, mathematics, medical device, physical sciences, U.K., university Researchers from University at Buffalo and a campus spin-off enterprise devised a way to expand the scope of anti-bacterial vaccines, as shown in tests with lab animals. . . . → Read More: Univ. Lab, Company Broaden Bacterial Vaccine Impact Comments are closed Intellectual property, New products biomedical, entrepreneurs, licensing, life sciences, pharmaceuticals, preclinical, university In this year’s survey of public companies by Forbes magazine, those from the tech industry are well represented among the best places to work. . . . → Read More: Infographic: World’s Best Employers National Multiple Sclerosis Society and the company Corrona LLC are establishing a registry of people with multiple sclerosis in North America to help assess the long-term safety and effectiveness of therapies approved to treat the disorder. . . . → Read More: Company, Foundation Start Multiple Sclerosis Registry Comments are closed Joint ventures/collaborations biomedical, health care, life sciences, pharmaceuticals, statistics Engineers in the U.K. developed a soft contact lens that in a clinical study shows it can reliably track changes in pressure inside the eye, a key factor in glaucoma. . . . → Read More: Contact Lens Devised to Measure Glaucoma Eye Pressure Comments are closed New products biomedical, clinical trials, engineering, Europe, life sciences, materials science, medical device, physical sciences, software, U.K., university First results of a clinical trial show a spray-on formulation of live bacteria reduced the amount and severity of acne in people with mild to moderate cases of the condition. . . . → Read More: Live Skin Bacteria Shown to Control Acne Comments are closed New products, Regulations biomedical, biotechnology, clinical trials, life sciences, pharmaceuticals An engineering team is creating a self-powered robot that can travel independently like a snake through uneven and cluttered surfaces, such as disaster sites. . . . → Read More: Snake-Like Intelligent Robot in Development One comment - (Comments are closed) Finance, New products computer science, engineering, grant, mathematics, NSF, physical sciences, robotics, software, university Drug maker Eli Lilly and Company and biotechnology company CureVac AG agreed to develop a series of cancer immunotherapies based on CureVac’s messenger RNA technology. . . . → Read More: Lilly, CureVac Partner on RNA Cancer Drugs in $1.8B Deal 2 comments - (Comments are closed) Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, cancer, equity, Europe, investment, licensing, life sciences, pharmaceuticals |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts